Learn More
Learn More
Learn More
Learn More
Learn More
With the 5th approval on CAR-T therapy (Abecma) by FDA in early 2021, ex vivo engineered T cell therapy was proved as a mainstay in cancer treatment.
05-19-2021 Dr. Lumeng Ye, Senior Scientist R&D department
Protein purification using traditional chromatography is limited by throughput and requires time-consuming, labor-intensive sample preparation processes.
05-13-2021 Sean Taylor
Western blotting is the most commonly used technique in the lab. However, the traditional workflow is time consuming, yet difficulties persist in obtaining consistent results. GenScript has developed instrument-based one-stop solutions to accelerate prote
05-06-2021 Dr. John Yu, Project Manager Catalogue Products
Covid Passport: Vaccination vs Immunization
04-30-2021 Prof Linfa Wang
With the 4th approval on CAR-T therapy (Breyanzi) by FDA in early 2021, ex vivo engineered T cell therapy was proved as a mainstay in cancer treatment.
04-28-2021 Lumeng Ye, Ph.D. Senior Scientist @Genscript, USA
Importance and challenge of COVID-19 serology
04-27-2021 Dr. Linfa Wang